Medical Exoskeleton Market

Global Medical Exoskeleton Market Size

The global medical exoskeleton market was valued at USD 46 million in 2025. The global market is projected to grow from USD 68.45 million in 2026 to reach USD 1,645 million by 2034, exhibiting a compound annual growth rate (CAGR) of 48.8% from 2026 to 2034.

A wearable hardware-software system called an exoskeleton is intended to help patients with lower limb impairments recover from their injuries. It wholly or partially restores the impaired motor function of the lower limbs. Patients might utilize it as a personal assistant as well. In exoskeletons, a frame encloses a specific area of the user's body. The frame is made of hard or soft material. Some of them contain sensors that monitor and react to wearers' movements which can even help wheelchair patients to get up and walk again since it can provide support and reduce fatigue.

MARKET DRIVERS

The global medical exoskeleton market is rising due to increasing technological advancements.

The new developments in an exoskeleton, such as the stroke and spinal cord injury exoskeleton, have made it easier for patients to stand back on their feet. However, the lives of orthopedic and spine patients differed considerably due to continuous innovations in the exoskeleton. According to the WHO, approximately 20 to 50 million people suffer non-fatal injuries each year, which leads to disability. Thus, medical exosuits supporting physical movement are expected to increase market value. Growing demand for effective rehabilitation approaches to drive medical exoskeleton market growth. The techniques make use of cutting-edge and novel items. This is a promising indicator for expanding the medical exoskeletons industry across all important geographies. The growing number of people with physical disabilities, rising investments in healthcare infrastructure spending, growing research and development activities, and the growing demand for innovative rehabilitation approaches led to increasing adaptation of exoskeleton devices. Additionally, the majority of orthopedic operations performed nowadays are knee and hip arthroplasties. Furthermore, according to WHO statistics published in February 2021, 1.71 billion individuals worldwide are thought to have musculoskeletal problems. As a result, exoskeleton systems are in more demand. Therefore, it is anticipated that the market for medical exoskeletons will grow throughout the forecast period due to the rising number of orthopedic operations.

MARKET RESTRAINTS

High costs associated with the exoskeletons, the stringent licensing requirements put forward by authorities for user safety insurance, and the variations in product testing owing to the technical design expertise and understanding of the manufacturers are some of the factors hampering the growth of the medical exoskeleton market. Also, the users face difficulty wearing and using the exosuit, and sometimes the device's failure can have life-threatening repercussions.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By End-User Insights

Based on the end-user, the healthcare segment is presumed to dominate the medical exoskeleton market due to the rising incidence rate of Spinal Cord Injuries (SCIs). Moreover, widespread adoption of these products and solutions in rehabilitation centers, a growing number of regulatory approvals, a significant surge in treatment numbers, rising awareness towards technologically advanced systems, and a rise in the adoption rate of exoskeleton products are some of the key factors driving the healthcare industry.Due to increasing public awareness of the advantages of exoskeleton technology in many industrial applications and the rising prevalence of work-related injuries, the industry segment is also predicted to experience substantial growth. Additionally, it is anticipated that the industrial segment will grow more quickly due to the spike in demand for breakthrough technologies and their increasing use in various industries, including manufacturing, distribution, and construction.

REGIONAL ANALYSIS

North America Medical Exoskeleton Market Analysis

The medical exoskeleton market in North America is expected to dominate by region. An estimated 61 million people in the United States have some disability, and 13.7% of them are suffering from mobility disabilities, as per the data published by the CDC. The North American medical exoskeleton market is further driven by the rising prevalence of chronic illness, rise in the number of rehabilitation centers, increasing elderly population, rise in prescriptions and hospitalization rates, and the increasing number of strokes. In addition, the strong presence of critical medical exoskeleton players, increase in government funding and healthcare expenditure, growing awareness of technological developments, surging demand for self-assist exoskeletons, and increase in the senior population is flourishing the medical exoskeleton market in the North American region.

Asia-Pacific Medical Exoskeleton Market Analysis

The medical exoskeleton market in the Asia-Pacific is anticipated to generate the highest CAGR in the global market owing to the growing number of exoskeleton developers actively developing innovative medical exoskeletons at affordable costs. Furthermore, a rise in the manufacture of medical exoskeletons for the defense sector, along with favorable government policies, are some of the factors driving the market. In addition, developing countries like China, Japan, and South Korea are expected to be significant revenue-generating economies.

KEY MARKET PLAYERS

Companies playing a notable role in the global medical exoskeleton market profiled in this report are

• Bioness Inc.
• B-Temia Inc.
• BIONIK Laboratories Corp
• CYBERDYNE INC.
• Ekso Bionics Holdings, Inc.
• EXOATLET
• GOGOA Mobility Robots
• Hocoma AG
• Wearable Robotics Srl
• Parker Hannifin Corporation
• ReWalk Robotics
• US Bionics, Inc.
• Tyromotion GmbH

GLOBAL MEDICAL EXOSKELETON MARKET NEWS

• In September 2022, ReWalk Robotics Ltd., a leading manufacturer of robotic medical technology for people with lower extremity disabilities, engaged with CMS in its commitment to evaluate complexly advanced. The latest step in ReWalk's efforts is to expand access to the Company's exoskeletons for Medicare beneficiaries with SCI.
• In September 2022, HMR's patented and disruptive medical technology dramatically improved mobility-challenged persons' rehabilitation with various distinguishing and innovative features. In addition, the Canadian government has contracted to purchase two units of HMR's next-generation lower-limb exoskeleton, XoMotion, a wearable robot.

MARKET SEGMENTATION

This research report on the global medical exoskeleton market has been segmented and sub-segmented based on component, extremity, end-user & region.

By Component

• Hardware

  • Sensor
  • Actuator
  • Control System
  • Power Source
• Software

By Extremity

• Upper Extremity
• Lower Extremity

By End-User

• Healthcare

• Industrial
• Military & Defence

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa